Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

CryoLife launches new surgical adhesive in Japan for aortic dissections

CryoLife : 26 April, 2011  (New Product)
CryoLife is launching its BioGlue Surgical Adhesive in Japan and the material expected to be available in hospitals by late May 2011.
BioGlue received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for use in the repair of aortic dissections in September 2010. Prior to distribution, MHLW completed a remote inspection of CryoLife pursuant to Japanese Quality Management System requirements and required product reimbursement paperwork for Japanese authorities.

CryoLife's partner, Century Medical (CMI) will distribute BioGlue in Japan for use in this subset of cardiac surgery. CryoLife will remain the exclusive supplier of BioGlue to CMI.

'We are pleased to have received Japanese approval for the use of BioGlue in the repair of aortic dissections, a potentially life-threatening condition if not properly repaired,' said Akira Hoshino, President and Chief Executive Officer of CMI. 'We believe that BioGlue is a valuable tool that will address many issues facing cardiac surgeons in Japan.'

'We are pleased that BioGlue is approved for this initial use in Japan. We estimate Japan to be the second largest market in the world for surgical haemostats and sealants,' said Steven Anderson, president and chief executive officer, CryoLife. 'Estimated to have been used in more than 615,000 procedures worldwide, BioGlue has proven to be a safe, efficacious product, and we look forward to continuing to expand both its applications and availability worldwide.'

The company estimates that the annual Japanese market for the use of surgical adhesives in the repair of aortic dissection is approximately $10 million, and the total annual market for the use of adhesives and sealants in Japan is approximately $150 million. The initial order is expected to be shipped in late April or early May and the company estimates approximately $600,000 in sales for the first 12 months to CMI, our exclusive distribution partner in Japan. As a part of its product launch, CMI and the company provided an introduction of BioGlue to approximately 110 physicians during The Japanese Society of Cardiovascular Surgery conference in Tokyo in February, and renowned cardiac surgeon, Dr John Fehrenbacher provided clinical data related to BioGlue usage at The Japanese Society for Vascular Surgery in Okinawa in April 2011.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo